21.1 Women with hypotension requiring intervention |
4 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
21.1.1 Bolus + infusion vs infusion |
1 |
80 |
Risk Ratio (M‐H, Random, 95% CI) |
3.50 [1.26, 9.72] |
21.1.2 0.5 mg/min vs 1 mg/min |
1 |
40 |
Risk Ratio (M‐H, Random, 95% CI) |
1.22 [0.65, 2.29] |
21.1.3 0.5 mg/min vs 2 mg/min |
1 |
40 |
Risk Ratio (M‐H, Random, 95% CI) |
1.57 [0.77, 3.22] |
21.1.4 0.5 mg/min vs 4 mg/min |
1 |
40 |
Risk Ratio (M‐H, Random, 95% CI) |
1.22 [0.65, 2.29] |
21.1.5 1 mg/min vs 2 mg/min |
3 |
107 |
Risk Ratio (M‐H, Random, 95% CI) |
1.24 [0.83, 1.84] |
21.1.6 1 mg/min vs 3 to 4 mg/min |
2 |
99 |
Risk Ratio (M‐H, Random, 95% CI) |
1.29 [0.81, 2.05] |
21.1.7 2 mg/min vs 3 to 4 mg/min |
2 |
239 |
Risk Ratio (M‐H, Random, 95% CI) |
1.21 [0.60, 2.43] |
21.2 Women with hypertension requiring intervention |
2 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
21.2.1 Bolus + infusion vs infusion |
1 |
80 |
Risk Ratio (M‐H, Random, 95% CI) |
1.00 [0.39, 2.59] |
21.2.2 0.5 mg/min vs 1 mg/min |
1 |
40 |
Risk Ratio (M‐H, Random, 95% CI) |
5.00 [0.26, 98.00] |
21.2.3 0.5 mg/min vs 2 mg/min |
1 |
40 |
Risk Ratio (M‐H, Random, 95% CI) |
0.67 [0.12, 3.57] |
21.2.4 0.5 mg/min vs 4 mg/min |
1 |
40 |
Risk Ratio (M‐H, Random, 95% CI) |
0.20 [0.05, 0.80] |
21.2.5 1 mg/min vs 2 mg/min |
1 |
40 |
Risk Ratio (M‐H, Random, 95% CI) |
0.14 [0.01, 2.60] |
21.2.6 1 mg/min vs 4 mg/min |
1 |
40 |
Risk Ratio (M‐H, Random, 95% CI) |
0.05 [0.00, 0.76] |
21.2.7 2 mg/min vs 4 mg/min |
1 |
40 |
Risk Ratio (M‐H, Random, 95% CI) |
0.30 [0.10, 0.93] |
21.3 Women with bradycardia |
1 |
19 |
Risk Ratio (M‐H, Random, 95% CI) |
Not estimable |
21.3.1 1 mg/min vs 2 mg/min |
1 |
19 |
Risk Ratio (M‐H, Random, 95% CI) |
Not estimable |
21.4 Women with nausea and/or vomiting |
3 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
21.4.1 Bolus + infusion vs infusion (nausea) |
1 |
80 |
Risk Ratio (M‐H, Random, 95% CI) |
1.83 [0.75, 4.48] |
21.4.2 0.5 mg/min vs 1 mg/min (nausea) |
1 |
40 |
Risk Ratio (M‐H, Random, 95% CI) |
1.29 [0.60, 2.77] |
21.4.3 0.5 mg/min vs 2 mg/min (nausea) |
1 |
40 |
Risk Ratio (M‐H, Random, 95% CI) |
1.50 [0.66, 3.43] |
21.4.4 0.5 mg/min vs 4 mg/min (nausea) |
1 |
40 |
Risk Ratio (M‐H, Random, 95% CI) |
1.29 [0.60, 2.77] |
21.4.5 1 mg/min vs 2 mg/min (nausea) |
2 |
60 |
Risk Ratio (M‐H, Random, 95% CI) |
2.19 [0.30, 15.85] |
21.4.6 1 mg/min vs 4 mg/min (nausea) |
1 |
40 |
Risk Ratio (M‐H, Random, 95% CI) |
1.00 [0.43, 2.33] |
21.4.7 2 mg/min vs 4 mg/min (nausea) |
1 |
40 |
Risk Ratio (M‐H, Random, 95% CI) |
0.86 [0.35, 2.10] |
21.4.8 Bolus + infusion vs infusion (vomiting) |
1 |
80 |
Risk Ratio (M‐H, Random, 95% CI) |
1.67 [0.43, 6.51] |
21.4.9 0.5 mg/min vs 1 mg/min (vomiting) |
1 |
40 |
Risk Ratio (M‐H, Random, 95% CI) |
0.67 [0.12, 3.57] |
21.4.10 0.5 mg/min vs 2 mg/min (vomiting) |
1 |
40 |
Risk Ratio (M‐H, Random, 95% CI) |
2.00 [0.20, 20.33] |
21.4.11 0.5 mg/min vs 4 mg/min (vomiting) |
1 |
40 |
Risk Ratio (M‐H, Random, 95% CI) |
2.00 [0.20, 20.33] |
21.4.12 1 mg/min vs 2 mg/min (vomiting) |
1 |
40 |
Risk Ratio (M‐H, Random, 95% CI) |
3.00 [0.34, 26.45] |
21.4.13 1 mg/min vs 4 mg/min (vomiting) |
1 |
40 |
Risk Ratio (M‐H, Random, 95% CI) |
3.00 [0.34, 26.45] |
21.4.14 2 mg/min vs 4 mg/min (vomiting) |
1 |
40 |
Risk Ratio (M‐H, Random, 95% CI) |
1.00 [0.07, 14.90] |
21.4.15 1 mg/min vs 2 mg/min (nausea or vomiting) |
1 |
19 |
Risk Ratio (M‐H, Random, 95% CI) |
8.18 [0.50, 133.66] |
21.5 Neonates with acidosis (pH < 7.2) |
2 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
21.5.1 Bolus + infusion vs infusion |
1 |
78 |
Risk Ratio (M‐H, Random, 95% CI) |
1.66 [0.53, 5.23] |
21.5.2 0.5 mg/min vs 1 mg/min |
1 |
40 |
Risk Ratio (M‐H, Random, 95% CI) |
0.33 [0.04, 2.94] |
21.5.3 0.5 mg/min vs 2 mg/min |
1 |
40 |
Risk Ratio (M‐H, Random, 95% CI) |
3.00 [0.13, 69.52] |
21.5.4 0.5 mg/min vs 4 mg/min |
1 |
40 |
Risk Ratio (M‐H, Random, 95% CI) |
0.25 [0.03, 2.05] |
21.5.5 1 mg/min vs 2 mg/min |
1 |
40 |
Risk Ratio (M‐H, Random, 95% CI) |
7.00 [0.38, 127.32] |
21.5.6 1 mg/min vs 4 mg/min |
1 |
40 |
Risk Ratio (M‐H, Random, 95% CI) |
0.75 [0.19, 2.93] |
21.5.7 2 mg/min vs 4 mg/min |
1 |
40 |
Risk Ratio (M‐H, Random, 95% CI) |
0.11 [0.01, 1.94] |
21.6 Neonatal Apgar score at 5 min |
3 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
21.6.1 Bolus + infusion vs infusion (Apgar < 7) |
1 |
80 |
Risk Ratio (M‐H, Random, 95% CI) |
Not estimable |
21.6.2 0.5 mg/min vs 1 mg/min (Apgar < 8) |
1 |
40 |
Risk Ratio (M‐H, Random, 95% CI) |
Not estimable |
21.6.3 0.5 mg/min vs 2 mg/min (Apgar < 8) |
1 |
40 |
Risk Ratio (M‐H, Random, 95% CI) |
Not estimable |
21.6.4 0.5 mg/min vs 4 mg/min (Apgar < 8) |
1 |
40 |
Risk Ratio (M‐H, Random, 95% CI) |
Not estimable |
21.6.5 1 mg/min vs 2 mg/min (Apgar < 8) |
2 |
59 |
Risk Ratio (M‐H, Random, 95% CI) |
Not estimable |
21.6.6 1 mg/min vs 4 mg/min (Apgar < 8) |
1 |
40 |
Risk Ratio (M‐H, Random, 95% CI) |
Not estimable |
21.6.7 2 mg/min vs 4 mg/min (Apgar < 8) |
1 |
40 |
Risk Ratio (M‐H, Random, 95% CI) |
Not estimable |